The News Feed

Diabetes

Men with DME Show More Inflammation on OCT than Women

Hyperreflective foci and thickening of the inner nuclear layer were more prominent in a recent study. Researchers speculate that estrogen may play a protective role.
July 23, 2024

FAF May Help Determine Need for Additional PRP in Proliferative DR

Study finds partially preserved photoreceptor integrity and sensitivity even in laser-treated areas of the retina.
July 17, 2024

UWF-FA Reveals DR Progression Associated with Nonperfusion

Neovascularization, however, was less strongly correlated with disease advancement in a large retrospective review of over one thousand images.
July 12, 2024

MD Groups Respond to Study Linking GLP-1 Treatment to NAION

The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.
July 11, 2024

Popular Type 2 Diabetes Drug Associated with Increased Risk of NAION

Though causality could not be determined, researchers observed a higher incidence of the event among patients on GLP-1 receptor agonists than those taking other diabetes or weight loss medications.
July 8, 2024

Over Four Million People Globally Experience Vision Impairment from DR

One-quarter of those affected are now blind, says a new meta-analysis. Prevalence is disproportionately higher in low-income regions and female populations.
July 2, 2024

Meta-analysis Says Oral Hypoglycemic Not Clearly Linked to Increased DR Risk

Studies on dipeptidyl peptidase-4 inhibitor use showed conflicting evidence and, ultimately, no significant change in risk or progression in patients with diabetes.
July 2, 2024

Controlling Hypertension Could Help Delay DR

A small study found that high blood pressure plays a large role in driving retinal arteriolar wall thickening in preclinical diabetic retinopathy.
June 19, 2024

Study Documents Increased DR Prevalence in Young Patients and Minorities

People aged 20 to 39 and those in Hispanic or Black ethnic/racial groups were most acutely affected, supporting the need for DR screening in young adults.
June 18, 2024

Type 2 Diabetes Drug May Reduce RVO Risk

Compared with DPP-4i, patients taking SGLT-2i had a significantly lower incidence of retinal vein occlusion, particularly branch RVO.
June 14, 2024